Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review

por Guirado, María, Fernández Martín, Elena, Fernández Villar, Alberto, Navarro Martín, Arturo, Sánchez-Hernández, Alfredo
Publicado 2022

Cutaneous reaction to ifosfamide plus mesna treated with desensitization challenge: a case report

por Delgado-Prada, Ana, Borrás, Julián, Farzanegan, Roxana, Torres Gorriz, María Cruz, Germán-Sánchez, Adrián, Cervera Aznar, Raquel, Raducan, Isabela, Castelló, Jose Vicente, Sanchez-Hernandez, Alfredo, Enrique, Ernesto
Publicado 2022

Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multi...

por Borrás Cuartero, Julián, Farzanegan Miñano, Roxana, Torres Gorriz, María Cruz, Germán Sánchez, Adrián, Aznar, Raquel Cervera, Raducan, Isabela, Castelló Carrascosa, Jose Vicente, Sanchez Hernandez, Alfredo, Enrique, Ernesto
Publicado 2022

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analy...

por Ferrarotto, Renata, Anderson, Ian, Medgyasszay, Balazs, García‐Campelo, Maria Rosario, Edenfield, William, Feinstein, Trevor M., Johnson, Jennifer M., Kalmadi, Sujith, Lammers, Philip E., Sanchez‐Hernandez, Alfredo, Pritchett, Yili, Morris, Shannon R., Malik, Rajesh K., Csőszi, Tibor
Publicado 2021

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation

por Serna-Blasco, Roberto, Sánchez-Herrero, Estela, Robado de Lope, Lucía, Sanz-Moreno, Sandra, Rodríguez-Festa, Alejandro, Ares-Trotta, Dunixe, Cruz-Bermúdez, Alberto, Franco, Fabio, Sánchez-Hernández, Alfredo, Campayo, María de Julián, García-Girón, Carlos, Dómine, Manuel, Blasco, Ana, Sánchez, José M., Oramas, Juana, Bosch-Barrera, Joaquim, Sala, María Á., Sereno, María, Romero, Atocha, Provencio, Mariano
Publicado 2022

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlle...

por Provencio, Mariano, Ortega, Ana Laura, Coves-Sarto, Juan, Calvo, Virginia, Marsé-Fabregat, Raquel, Dómine, Manuel, Guirado, María, Carcereny, Enric, Fernández, Natalia, Álvarez, Ruth, Blanco, Remei, León-Mateos, Luis, Sánchez-Torres, José Miguel, Sullivan, Ivana Gabriela, Cobo, Manuel, Sánchez-Hernández, Alfredo, Massuti, Bartomeu, Sierra-Rodero, Belen, Mártinez-Toledo, Cristina, Serna-Blasco, Roberto, Romero, Atocha, Cruz-Bermúdez, Alberto
Publicado 2022